RAPPORT THERAPEUTICS INCRAPP

Neutral

ASignal's systematic analysis rates RAPP as Neutral.

Reflects the latest available analysis · analyzed Sep 10, 2026

The case on RAPP

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong cash position with $436.08M in total cash
  • Low debt-to-equity ratio of 0.02x indicating minimal leverage risk
  • High current and quick ratios (15.72x and 15.35x) suggesting strong short-term liquidity
  • RSI near 35, indicating potential oversold condition
VS
Bear case
  • Negative operating and gross margins (-767.58% and -109.39%) reflecting significant unprofitability
  • Negative free cash flow of $-56.02M and negative operating cash flow of $-96.68M
  • Extremely high valuation metrics: price-to-sales of 104.26x and EV/revenue of 83.98x
  • Negative return on equity (-39.96%) and return on assets (-25.78%)
  • MACD below signal line with negative histogram, indicating bearish momentum
  • Price trading below 20-day and 50-day moving averages
Subscriber-only

See the full verdict on RAPP

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes RAPP

Most investors never get a second opinion, let alone several. ASignal runs RAPP past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

RAPPORT THERAPEUTICS INC (RAPP) Stock Analysis - ASignal rates it Neutral